U of M researchers have effectively treated muscular dystrophy in mice using human stem cells. Rita Perlingeiro, Medical School, and John Wagner, Medical School, Stem Cell Institute, Masonic Cancer Center and University of Minnesota Physicians, talk about what this means for future treatment in humans.
Listen on WCCO
Read on FOX 9
For the past five years Jonathan Slack, Medical School and Stem Cell Institute, has influenced the education and research opportunities at the University. At the end of this calendar he will be stepping down as the director as the Stem Cell Institute.
Amplatz Children's Hosptial will be conducting the first ever cord blood transplant soon. John Wagner, Medical School, Masonic Cancer Center, Stem Cell Institute and University of Minnesota Physicians, explains the transfer could cure the patients leukemia.
John Ohlfest, Medical School, Masonic Cancer Center, Stem Cell Institute and University of Minnesota Physicians, and Chris Moertel, Medical School and University of Minnesota Physicians, discuss an upcoming neuro-oncology symposium and current research here at the U of M.
Susan G. Komen Foundation has recently decided not to support embryonic stem cell research. Dan Kaufman, Medical School, Masonic Cancer Center, Stem Cell Institute and University of Minnesota Physicians, discusses how his research with these cells have killed cancerous tumors in rats.
Fueled by $500,000 a year from the fund, U brain researchers are hoping to turn nano ideas into mega results. David Redish, Kenneth Baker, Marilyn Carroll, Gulin Oz, Medical School, and Yasushi Nakagawa, Medical School and Stem Cell Institute, talk about their projects.
The search for a cure, or even a less-complicated treatment, is still on a long road to its goal. Meri Firpo, Medical School, Stem Cell Institute, Schulze Diabetes Institute and University of Minnesota Physicians, explains why stem cell therapies are perfect for diabetes research.
Researchers have identified gene biomarkers that can predict whether or not patients with advanced stages of ovarian cancer will respond to chemotherapy. Jason Nikas, Stem Cell Institute, explains his research and what it means for physicians.
Scientists are on the brink of radically expanding the span of a healthy life. Doris Taylor, Medical School and Stem Cell Institute, discusses the health technology of tomorrow.





